ID   A375P-5
AC   CVCL_RN37
DR   cancercelllines; CVCL_RN37
DR   Wikidata; Q54606871
RX   PubMed=2731157;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6233 ! A375-P
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 12
//
RX   PubMed=2731157; DOI=10.1016/0304-3835(89)90148-1;
RA   Yohem K.H., Seftor E.A., Meyskens F.L. Jr., Hendrix M.J.C.;
RT   "Cloning efficiency of human melanoma cells is modulated after
RT   invasion through a reconstituted basement membrane.";
RL   Cancer Lett. 45:135-143(1989).
//